Castle Biosciences Inc. (CSTL) Tops Q3 EPS by 50c

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q3 EPS of ($0.02), $0.50 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $83 million versus the consensus estimate of $71.03 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• Uber sells part of its Aurora stake in block trade - Bloomberg
• Boeing-Lockheed’s ULA triples bond sale to $1.5 billion - report